Australia's largest stock trading and investment forum Australia's #1 stock forum

RAC

Click for more information

0.57%

$1.75 race oncology ltd

The first rule of FTO club is 'you do not talk about FTO'

First 54 Last

Share
Profile

Follow
cas33VFL

917 Posts.

228

07/03/24

20:46

Post #: 72802219
Share

Originally posted by KingBuzzo: ↑

The 'Cellular Pathway' section makes no mention of FTO. Not that I can pretend to understand any of that section, but I'll admit that the lack of a mention of FTO anywhere other than the introduction surprised me somewhat. Does this mean that the MoA for Bisantrene working with Decitabine in AML is not related to FTO?

Also, a couple of other questions:
1) How accurate are these AML mouse models typically when being translated into humans? In the past you've mentioned some mouse models are very accurate (e.g. for cardioprotection) and others not necessarily so - where do these AML models fit in the spectrum?

2) In regards to the dosing of Bisantrene in this work, what would be the equivalent dose in a human if the dosing was directly extrapolated from what was used in the mice (if it is even possible to extrapolate)? As I understand it, the Bis/Dec combo dosing in the (hopefully) upcoming AML trial will be 'low intensity' and thus I'm assuming the dosage of Bisantrene will be much lower than the historical 'chemotherapeutic' dosing, but do we know how much lower exactly and was that reflected in the study presented here?

Thank you in advance for your responses.

Expand

The first rule of FTO club is 'you do not talk about FTO'

RAC Price at posting: $1.02 Sentiment: Buy Disclosure: Held
26 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

There are more pages in this discussion • 36 more messages in this thread...

First 54 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.75		Change 0.010(0.57%)		Mkt cap ! $298.0M

Open	High	Low	Value	Volume
$1.73	$1.83	$1.73	$272.0K	152.3K

Buyers (Bids)

No.	Vol.	Price($)
1	9998	$1.75

Sellers (Offers)

Price($)	Vol.	No.
$1.79	2000	1

View Market Depth

No.	Vol.	Price($)
1	9998	1.750
1	7599	1.730
1	581	1.720
3	11557	1.710
4	46280	1.700

Price($)	Vol.	No.
1.790	2000	1
1.830	44030	2
1.840	10500	2
1.850	14500	3
1.860	949	2

Last trade - 16.10pm 09/07/2024 (20 minute delay)

RAC (ASX) Chart